Articles

Worldwide, over 1.2 million deaths are attributed to antimicrobial-resistant pathogens each year. Left unaddressed, experts estimate annual deaths could jump to 10 million by 2050.

PATH has taken an active role in developing, introducing, and scaling self-testing in low- and middle-income countries.

PATH is using innovative, scalable technology solutions to digitize health programs and enhance the quality and sustainability of care.

Ashley Birkett, PhD, head of PATH’s Malaria Vaccine Initiative, talks about next steps for RTS,S and work to develop the next generation of malaria vaccines and biologics.